Article
Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer.
BioMed research international - 1 Jan 2021
Xu Zhiquan, Xiang Ling, Wang Rong, Xiong Yongfu, Zhou He, Gu Haitao, Wang Jijian, Peng Linglong
Abstract excerpt
BACKGROUND: Currently, immunotherapy is widely used for breast cancer (BC) patients, and tumor mutation burden (TMB) is regarded as a valuable independent predictor of response to immunotherapy. However, specific gene mutations and their relationship with TMB and tumor-infiltrating immune cells in BC are not fully understood. METHODS: Comprehensive bioinformatic analyses were performed using data from The Cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
